CUSIP: 36118A100
What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 36118A100:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q2 | 0 | $0 | -$1,471,914,726 | 0 | |
| 2024 Q1 | 69,088,929 | $1,472,970,461 | +$304,054,766 | $21.32 | 114 |
| 2023 Q4 | 60,795,560 | $584,055,812 | +$104,586,597 | $9.61 | 77 |
| 2023 Q3 | 49,899,434 | $129,738,352 | -$960,412 | $2.60 | 39 |
| 2023 Q2 | 50,257,178 | $234,890,057 | +$22,506,822 | $4.67 | 40 |
| 2023 Q1 | 45,577,701 | $171,776,024 | +$66,789,374 | $3.77 | 36 |
| 2022 Q4 | 28,182,825 | $88,776,644 | -$1,248,182 | $3.15 | 28 |
| 2022 Q3 | 26,582,690 | $80,314,943 | -$2,694,667 | $3.01 | 31 |
| 2022 Q2 | 27,860,051 | $69,370,408 | -$1,031,719 | $2.49 | 31 |
| 2022 Q1 | 28,219,611 | $219,062,395 | +$4,373,695 | $7.77 | 28 |
| 2021 Q4 | 27,767,922 | $115,956,125 | -$626,799 | $4.17 | 30 |
| 2021 Q3 | 27,852,055 | $220,616,238 | +$2,907,083 | $7.92 | 39 |
| 2021 Q2 | 27,482,973 | $221,752,242 | -$1,174,862 | $8.08 | 37 |
| 2021 Q1 | 27,602,138 | $295,864,322 | +$3,312,121 | $10.72 | 37 |
| 2020 Q4 | 27,229,348 | $319,948,353 | -$261,229 | $11.75 | 36 |
| 2020 Q3 | 25,647,999 | $306,186,361 | -$39,971,461 | $12.02 | 29 |
| 2020 Q2 | 28,173,365 | $482,962,368 | +$482,931,368 | $17.47 | 51 |